January 1, 2022, René Geci joins esqLABS as external PhD

René Geci is a Systems Biologist who recently finished his master’s degree and now joins us as our first PhD student in collaboration with the RWTH Aachen (Germany) under…..

October 1, 2021, Dr. Alicia Paini joins esqLABS

Alicia will lead research programs on developing and applying physiologically based kinetic (PBK) models and developing strategies for new approach methodologies for chemical risk assessment…..

esqLABS provides training to US FDA Scientists on the use of the OSP Suite (PK-Sim® and MoBi®) for PBPK and QSP modeling and simulation

esqLABS has had the privilege to provide a detailed 3-day training to 15 Scientists from the U.S. Food and Drug Administration Division of Pharmacometrics, Office of Clinical Pharmacology …

esqLABS joins EU project ONTOX

esqLABS is partnering with 17 institutions across the EU and the US to further develop computational approaches for next-generation risk assessment (NGRA) to provide a solution for advancing human risk assessment of chemicals without the use of animals…

2020 in Review for the OSP (PK-Sim & MoBi) Development Team

While the world seemed to stay still, this year was full of (e)motions for the Open Systems Pharmacology Community. esqLABS is thrilled to contribute to this initiative and witness its continued success …

2020 in Review for the esqLABS Team

What a year 2020! The esqLABS team has more than doubled in size and continues to grow: we now employ 8 great personalities from around the globe …

The Virtual (ACoP11) Conference Experience

The first virtual American Conference on Pharmacometrics (ACoP) from 9-13 November managed to satisfy both, esqLABS scientific curiosity and business development. The diversity of scientific topics and …

News

esqLABS joins EU project ONTOX

esqLABS is partnering with 17 institutions across the EU and the US to further develop computational approaches for next-generation risk assessment (NGRA) to provide a solution for advancing human risk assessment of chemicals without the use of animals…

Upcoming Events

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

News archive

October 1, 2021, Dr. Alicia Paini joins esqLABS

Alicia will lead research programs on developing and applying physiologically based kinetic (PBK) models and developing strategies for new approach methodologies for chemical risk assessment…..

2021 in Review for the esqLABS Team

In 2021, for our fourth year, esqLABS has again grown in numbers. After doubling our size in 2020, we were again able to grow our the esqLABS family by …

July 1, 2021, Dr. Luis David Jimenez Franco joins esqLABS

Dr. Huan Yang is a mathematical modeler, who is passionate about computational modeling, data analysis, and machine learning for life-science innovation. Before joining esqLABS, Huan has applied systems modeling…

esqLABS joins EU project ONTOX

esqLABS is partnering with 17 institutions across the EU and the US to further develop computational approaches for next-generation risk assessment (NGRA) to provide a solution for advancing human risk assessment of chemicals without the use of animals…

April 1, 2021, Dr. Huan Yang joins esqLABS

Dr. Huan Yang is a mathematical modeler, who is passionate about computational modeling, data analysis, and machine learning for life-science innovation. Before joining esqLABS, Huan has applied systems modeling…

2020 in Review for the esqLABS Team

What a year 2020! The esqLABS team has more than doubled in size and continues to grow: we now employ 8 great personalities from around the globe …

The Virtual (ACoP11) Conference Experience

The first virtual American Conference on Pharmacometrics (ACoP) from 9-13 November managed to satisfy both, esqLABS scientific curiosity and business development. The diversity of scientific topics and …

May 23, 2020, Dr. Abdel Rodriguez joins esqLABS

Dr. Abdel Rodríguez is a Computer Scientist with academic and industrial experience. He has balanced theory and practice experience in the field of Computer Science. He holds a MSc in Bioinformatics, a PhD in Machine Learning and more …

May 18, 2020, Dr. Frederico Severino Martins joins esqLABS

Dr. Frederico Martins is pharmacist with a PhD in Pharmaceutical Sciences from the University of São Paulo, Brazil. Prior to joining esqLABS, Dr. Martins worked as a pharmacometrics leader at Galapagos Pharmaceuticals in Paris …

May 1, 2020, Dr. Christian Maass joins esqLABS

Christian Maass is a physicist and computational biologist with over eight years of academic and industrial experience, where he established a strong national and international network. He is passionate about the integration …

May 1, 2020, Georgios Daskalakis joins esqLABS

Georgios Daskalakis is an experienced Software Developer with over 4 years of customer centric experience in software development in various fields. He started programming for BTC AG, contributing to the further …

esqLABS developing clinical decision support system

From within the „MoDiPro“ collaborations network, esqLABS & Partners have submitted a grant application for the GlucoSys Project. GlucoSys aims at developing a new technology solution for the control of blood glucose of intensive care patients in ICU wards…

June 22-26, 2018: esqLABS is @ ADA 78th Scientific Sessions

esqlabs will be @ American Diabetes Association’s 78th Scientific Sessions in Orlando, Florida. Reach out to us if you want to know how we can help you assess efficacy and outcome of novel Technology and Treatments in Diabetes using our PB-QSP Diabetes Platform....

May 31, 2018: esqLABS and Sanofi present @ PAGE 2018

esqLABS is presenting with Sanofi-Aventis Deutschland GmbH about their work to advance the translational capabilities of the PB-QSP Diabetes platform by supporting M&S for preclinical species…

esqLABS advancing OSPS

esqLABS is partnering with the Saarland University and the Bayer AG for the public-funding project OSMOSES to further develop the OPEN SOURCE software Open Systems Pharmacology Suite. The overall aim of the OSMOSES project is the further development of the “Open Systems…

January 1, 2018, Pavel Balazki joins esqLABS

Pavel is an interdisciplinary scientist with a solid experience in physiological modeling and programming skills. He focuses on the combination of modeling and software development to offer QSP platforms as integrated solutions…

November 29, 2017: esqLABS joins MoDiPro

„MoDiPro“ delivers innovative „Industry 4.0“ concepts for the Biotech and Health Care Industries. Within the collaborations network, partners from industry and academia work on joint R&D projects to develop smart devices and predictive computer (simulation-) models for digital decision support systems…

June 22, 2017: esqLABS is founded

esqLABS GmbH is founded as a German Limited Liability Company and registered with the register of commerce in Oldenburg, Germany.

Past events

PAGE 2022 (June 28th): 1-Day OSP Suite Workshop & Webinar

esqLABS is conducting a FREE workshop on Tuesday, June 28th, demonstrating the application of PK-Sim® and MoBi® (OSP-Suite, www.open-systems-pharmacology.org) for use in physiologically-based pharmacokinetic (PBPK) and quantitative systems pharmacology (QSP) …

September 19, 2019: PBPK/PD Workshop in Boston, MA

esqLABS is running a one-day hands-on workshop on “PBPK/PD of Small Molecules and Antibodies with PK-Sim & MoBi (OSP Suite)” on Thursday 19th of September at the Workbar (Big Bang Room), 45 Prospect St, Cambridge, MA 02139…

Get in touch now

Contact

esqLABS GmbH | Hambierich 34 | 26683 Saterland | Germany
Tel. +49 151 / 58559070 | info@esqLABS.com